The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 20, 2025

Filed:

Jun. 03, 2019
Applicant:

Diatheva S.r.l., Cartoceto, IT;

Inventors:

Valentina Fiori, Fano, IT;

Sabrina Dominici, Fermignano, IT;

Diego Moricoli, Fano, IT;

Maria Elena Laguardia, Colli Al Metauro, IT;

Cosimo Damiano Carbonella, Fano, IT;

Maria Cristina Balducci, Fano, IT;

Assignee:

DIATHEVA S.R.L., Cartoceto, IT;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 16/28 (2006.01); A61K 39/00 (2006.01); A61P 35/02 (2006.01);
U.S. Cl.
CPC ...
C07K 16/2896 (2013.01); A61P 35/02 (2018.01); A61K 2039/505 (2013.01); C07K 2317/565 (2013.01); C07K 2317/622 (2013.01);
Abstract

The present invention relates to a multivalent, preferably bivalent, antibody complex, more preferably a diabody, i.e. a bivalent scFv, capable of recognizing and binding the human protein CD99, a composition comprising said complex and the use thereof for diagnostic purposes and/or for the treatment and/or the follow-up of leukaemias and/or myelodysplastic syndromes. Furthermore, the present invention relates to antibodies, preferably monoclonal, of the immunoglobulins G group type capable of recognizing and binding the human protein CD99, a composition comprising said immunoglobulins and the medical use thereof, in particular for the treatment and/or the follow-up of cancer, preferably solid tumours that express CD99 and/or leukaemias and/or myelodysplastic syndromes.


Find Patent Forward Citations

Loading…